Search Results - "WOLOSZCZUK, Wolfgang"

Refine Results
  1. 1

    Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy by Stefenelli, T, Mayr, H, Bergler-Klein, J, Globits, S, Woloszczuk, W, Niederle, B

    Published in The American journal of medicine (01-08-1993)
    “…This prospective study was designed to assess the effect of primary hyperparathyroidism on heart muscle, valves, and myocardial function. Echocardiography was…”
    Get more information
    Journal Article
  2. 2

    Bisphosphonate Treatment does not Affect Serum Levels of Osteoprotegerin and RANKL in Hypercalcemic Cancer Patients by ZOJER, Niklas, BRENNER, Karin, BEKE, Dora, KUDLACEK, Stefan, HAWA, Gerhard, WOLOSZCZUK, Wolfgang, HOFBAUER, Lorenz C, PECHERSTORFER, Martin

    Published in Anticancer research (01-09-2005)
    “…Bisphosphonates are the standard treatment for hypercalcemia of malignancy. We hypothesized that bisphosphonate treatment and the subsequent fall in serum…”
    Get full text
    Journal Article
  3. 3

    Plasma Ghrelin Concentrations Are Not Regulated by Glucose or Insulin by Schaller, Georg, Schmidt, Adele, Pleiner, Johannes, Woloszczuk, Wolfgang, Wolzt, Michael, Luger, Anton

    Published in Diabetes (New York, N.Y.) (01-01-2003)
    “…Plasma Ghrelin Concentrations Are Not Regulated by Glucose or Insulin A Double-Blind, Placebo-Controlled Crossover Clamp Study Georg Schaller 1 , Adele Schmidt…”
    Get full text
    Journal Article
  4. 4

    Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients by Frey, B, Pacher, R, Locker, G, Bojic, A, Hartter, E, Woloszczuk, W, Stanek, B

    Published in Chest (01-06-2000)
    “…To compare hemodynamics and plasma big endothelin levels in patients awaiting heart transplantation who are receiving continuous IV therapy, and to establish…”
    Get more information
    Journal Article
  5. 5

    Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes by Pena, Michelle J, de Zeeuw, Dick, Mischak, Harald, Jankowski, Joachim, Oberbauer, Rainer, Woloszczuk, Wolfgang, Benner, Jacqueline, Dallmann, Guido, Mayer, Bernd, Mayer, Gert, Rossing, Peter, Lambers Heerspink, Hiddo J

    Published in Nephrology, dialysis, transplantation (01-08-2015)
    “…Diabetic kidney disease occurs in ∼ 25-40% of patients with type 2 diabetes. Given the high risk of progressive renal function loss and end-stage renal…”
    Get full text
    Journal Article
  6. 6

    Plasma ghrelin concentrations are not regulated by glucose or insulin: A double-blind, placebo-controlled crossover clamp study by SCHALLER, Georg, SCHMIDT, Adele, PLEINER, Johannes, WOLOSZCZUK, Wolfgang, WOLZT, Michael, LUGER, Anton

    Published in Diabetes (New York, N.Y.) (2003)
    “…Ghrelin plasma concentrations increase during fasting and fall rapidly after nutrient ingestion. We hypothesized that insulin or glucose could regulate ghrelin…”
    Get full text
    Journal Article
  7. 7

    Primary hyperparathyroidism and the heart: Cardiac abnormalities correlated to clinical and biochemical data by Längle, Friedrich, Abela, Claudette, Koller‐Strametz, Janette, Mittelböck, Martina, Bergler‐Klein, Jutta, Stefenelli, Thomas, Woloszczuk, Wolfgang, Niederle, Bruno

    Published in World journal of surgery (01-07-1994)
    “…Comparing patients with primary hyperparathyroidism (PHP) to a normocalcemic control population, those with PHP have a higher incidence of cardiovascular…”
    Get full text
    Journal Article Conference Proceeding
  8. 8
  9. 9

    Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: A consensus advice from an Austrian working group by Bieglmayer, Christian, Dimai, Hans Peter, Gasser, Rudolf Wolfgang, Kudlacek, Stefan, Obermayer-Pietsch, Barbara, Woloszczuk, Wolfgang, Zwettler, Elisabeth, Griesmacher, Andrea

    Published in Wiener medizinische Wochenschrift (01-11-2012)
    “…Summary Aim Reasonable application of laboratory parameters in prevention, diagnosis, treatment and therapy monitoring of osteoporosis. Target groups…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction by Skoumal, Martin, Haberhauer, Günther, Kolarz, Gernot, Hawa, Gerhard, Woloszczuk, Wolfgang, Klingler, Anton

    Published in Arthritis research & therapy (01-01-2005)
    “…Cathepsin K is a cysteine protease that plays an essential role in osteoclast function and in the degradation of protein components of the bone matrix by…”
    Get full text
    Journal Article
  11. 11

    Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation by Schwarz, Christoph, Mitterbauer, Christa, Heinze, Georg, Woloszczuk, Wolfgang, Haas, Martin, Oberbauer, Rainer

    Published in Kidney international (01-01-2004)
    “…Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation. We recently showed that two doses of 4mg of…”
    Get full text
    Journal Article
  12. 12

    The effect of age and gender on cytokine production by human peripheral blood mononuclear cells and markers of bone metabolism by Pietschmann, Peter, Gollob, Eva, Brosch, Susanne, Hahn, Philipp, Kudlacek, Stephan, Willheim, Martin, Woloszczuk, Wolfgang, Peterlik, Meinrad, Tragl, Karl Heinz

    Published in Experimental gerontology (01-10-2003)
    “…Background. Aging has been associated with various alterations of immune functions, the musculoskeletal system and a decline of sex hormone levels. Estradiol…”
    Get full text
    Journal Article
  13. 13
  14. 14

    High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy by Mikosch, Peter, Kerschan-Schindl, Katharina, Woloszczuk, Wolfgang, Stettner, Haro, Kudlacek, Stefan, Kresnik, Ewald, Gallowitsch, Hans J, Lind, Peter, Pietschmann, Peter

    Published in Thyroid (New York, N.Y.) (01-01-2008)
    “…Thyroid hormone administration is associated with low bone density in some studies. The aim of the present study was to evaluate the influence L-thyroxine, in…”
    Get more information
    Journal Article
  15. 15

    The imbalance between osteoprotegerin and cathepsin K in the serum of patients with longstanding rheumatoid arthritis by Skoumal, Martin, Haberhauer, Günther, Kolarz, Gernot, Hawa, Gerhard, Woloszczuk, Wolfgang, Klingler, Anton, Varga, Franz, Klaushofer, Klaus

    Published in Rheumatology international (01-05-2008)
    “…Osteoprotegerin (OPG) and soluble receptor activator of NF-kappa B ligand (sRANKL) together regulate the bone metabolism among other cytokines, whereby…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19 by Deftos, L J, Woloszczuk, W, Krisch, I, Horvat, G, Ulrich, W, Neuhold, N, Braun, O, Reiner, A, Srikanta, S, Krisch, K

    Published in The American journal of medicine (01-12-1988)
    “…A number of endocrine peptides and proteins are expressed by medullary thyroid carcinoma (MTC). The expression of two newly appreciated neuroendocrine tumor…”
    Get more information
    Journal Article
  18. 18

    Endurance running acutely raises plasma osteoprotegerin and lowers plasma receptor activator of nuclear factor κ B ligand by Ziegler, Sophie, Niessner, Alexander, Richter, Bernhard, Wirth, Susan, Billensteiner, Elke, Woloszczuk, Wolfgang, Slany, Jörg, Geyer, Georg

    Published in Metabolism, clinical and experimental (01-07-2005)
    “…The balance of the 2 cytokines, osteoprotegerin (OPG) and the receptor activator of nuclear factor κ B ligand (soluble (s)RANKL), is known to have considerable…”
    Get full text
    Journal Article
  19. 19
  20. 20